PrimeX News

Dow Jones and S&P 500 Forecast: Tariffs Test Rally as Dow Targets 55,000
Sat, 04 Jul 2026 10:40:17 GMT
CRISPR Therapeutics (CRSP) Price Forecast: Dual Breakout Targets Higher Prices
Fri, 03 Jul 2026 21:05:39 GMT
Natural Gas Price Forecast: Breakout or Breakdown Ahead?
Fri, 03 Jul 2026 20:46:26 GMT
Gold (XAU/USD) Price Forecast: Above Trendline Signals Recovery
Fri, 03 Jul 2026 20:45:41 GMT
Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Prices Move Away From Multi-Month Lows
Fri, 03 Jul 2026 19:12:15 GMT
Is Gold About to Unleash the Biggest Comeback Trade of 2026?
Fri, 03 Jul 2026 18:54:00 GMT

From Currencies to Commodities: Leveraging Gold Ratios in Trading
Thu, 25 Jun 2026 12:59:13 GMT
First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

MLTX

MoonLake Immunotherapeutics Class A Ordinary Shares

18.95

USD

0.00

0.00%

Jul 03, 09:30 UTC -4

Closed

exchange

After-Market

18.93

-0.02

-0.08%

MLTX News & Forecasts

featured

The Motley Fool

MoonLake Immunotherapeutics' CFO Sells 39K Shares

featured

MoonLake: 'Buy' Sonelokimab BLA Submission HS September And Label Expansion

featured

The Motley Fool

Why MoonLake Immunotherapeutics Stock Wilted on Wednesday

featured

MoonLake Immunotherapeutics: Label Upside Drives The Next Leg Higher

featured

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript

featured

FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soars

featured

Investors Business Daily

MoonLake Clears A Key Regulatory Hurdle, And Shares Rocket

featured

The Motley Fool

The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?

featured

The Motley Fool

Biotech Fund BVF Trims MoonLake Stake, Sells $63M in Shares

Advertisement

Advertisement

Advertisement